Bicara Therapeutics Inc (NASDAQ:BCAX) shares, rose in value on Friday, May 09, with the stock price down by -1.22% to the previous day’s close as strong demand from buyers drove the stock to $12.97.
Actively observing the price movement in the last trading, the stock closed the session at $13.13. Referring to stock’s 52-week performance, its high was $28.09, and the low was $8.91. On the whole, BCAX has fluctuated by 24.71% over the past month.
With the market capitalization of Bicara Therapeutics Inc currently standing at about $707.33 million, investors are eagerly awaiting this quarter’s results, scheduled for in June.
The stock’s technical analysis shows that the price of BCAX currently trading nearly -3.06% and -1.03% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 48.44, while the 7-day volatility ratio is showing 10.78% which for the 30-day chart, stands at 11.61%. Furthermore, Bicara Therapeutics Inc (BCAX)’s average true range (ATR) is 1.40.
Data on historical trading for Bicara Therapeutics Inc (NASDAQ:BCAX) indicates that the trading volumes over the past 3 months, they’ve averaged 540.47K. According to company’s latest data on outstanding shares, there are 54.44 million shares outstanding.
Nearly 43.23% of Bicara Therapeutics Inc’s shares belong to company insiders and institutional investors own 56.02% of the company’s shares. The stock has fallen by -25.55% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the BCAX stock heading into the next quarter.
